Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Seizure
|
December 29, 2007
Sexual problems in males with epilepsy--an interdisciplinary challenge!
Eva Hellmis
Der Urologe. Ausg. A
|
February 12, 2021
[Treatment of nonmetastatic CRPC : Androgen receptor inhibition as new treatment standard in nonmetastatic castration-resistant prostate cancer with high risk of metastasis]
Boris Hadaschik, Eva Hellmis
Aktuelle Urologie
|
March 27, 2023
[Prostate Cancer: Side-Effect Management for Androgen Deprivation Therapy]
Eva Hellmis, Tobias Niels Mudra, Axel S Merseburger
Aktuelle Urologie
|
March 19, 2021
[Apalutamide in patients with high-risk M0CRPC: data from the pivotal SPARTAN study and initial experience from a compassionate use program]
Eva Hellmis, Christian Schwentner, Philipp Mandel, et al.
Aktuelle Urologie
|
February 23, 2021
[Apalutamide in patients with high-risk M0CRPC: data from the pivotal SPARTAN study and initial experience from a compassionate use program]
Eva Hellmis, Christian Schwentner, Philipp Mandel, et al.
The Journal of Nutrition
|
December 25, 2007
Lycopene inhibits disease progression in patients with benign prostate hyperplasia
Silke Schwarz, Ute C Obermüller-Jevic, Eva Hellmis, et al.
Aktuelle Urologie
|
September 27, 2022
[Retrospective practice-related care research study on therapy of mCPRC with radium-223 dichloride]
Charlotte Jores, Frank König, Eva Hellmis, et al.
Future Oncology (London, England)
|
April 14, 2026
Saruparib in combination with androgen receptor pathway inhibitors in metastatic hormone-sensitive prostate cancer: EvoPAR-Prostate01
Arun A Azad, Neeraj Agarwal, Andrew J Armstrong, et al.
Aktuelle Urologie
|
October 24, 2022
[Retrospective practice-related care research study on therapy of mCPRC with radium-223 dichloride]
Charlotte Jores, Frank König, Eva Hellmis, et al.
Urologie (Heidelberg, Germany)
|
April 13, 2026
[Update of S3 guideline on metastatic prostate cancer-guideline recommendations and expert consensus]
Marc-Oliver Grimm, Christian Gratzke, Boris Hadaschik, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Seizure
|
December 29, 2007
Sexual problems in males with epilepsy--an interdisciplinary challenge!
Eva Hellmis
Der Urologe. Ausg. A
|
February 12, 2021
[Treatment of nonmetastatic CRPC : Androgen receptor inhibition as new treatment standard in nonmetastatic castration-resistant prostate cancer with high risk of metastasis]
Boris Hadaschik, Eva Hellmis
Aktuelle Urologie
|
March 27, 2023
[Prostate Cancer: Side-Effect Management for Androgen Deprivation Therapy]
Eva Hellmis, Tobias Niels Mudra, Axel S Merseburger
Aktuelle Urologie
|
March 19, 2021
[Apalutamide in patients with high-risk M0CRPC: data from the pivotal SPARTAN study and initial experience from a compassionate use program]
Eva Hellmis, Christian Schwentner, Philipp Mandel, et al.
Aktuelle Urologie
|
February 23, 2021
[Apalutamide in patients with high-risk M0CRPC: data from the pivotal SPARTAN study and initial experience from a compassionate use program]
Eva Hellmis, Christian Schwentner, Philipp Mandel, et al.
The Journal of Nutrition
|
December 25, 2007
Lycopene inhibits disease progression in patients with benign prostate hyperplasia
Silke Schwarz, Ute C Obermüller-Jevic, Eva Hellmis, et al.
Aktuelle Urologie
|
September 27, 2022
[Retrospective practice-related care research study on therapy of mCPRC with radium-223 dichloride]
Charlotte Jores, Frank König, Eva Hellmis, et al.
Future Oncology (London, England)
|
April 14, 2026
Saruparib in combination with androgen receptor pathway inhibitors in metastatic hormone-sensitive prostate cancer: EvoPAR-Prostate01
Arun A Azad, Neeraj Agarwal, Andrew J Armstrong, et al.
Aktuelle Urologie
|
October 24, 2022
[Retrospective practice-related care research study on therapy of mCPRC with radium-223 dichloride]
Charlotte Jores, Frank König, Eva Hellmis, et al.
Urologie (Heidelberg, Germany)
|
April 13, 2026
[Update of S3 guideline on metastatic prostate cancer-guideline recommendations and expert consensus]
Marc-Oliver Grimm, Christian Gratzke, Boris Hadaschik, et al.
Page
of 2